
Lynx.MD revolutionizes specialty medicine by providing a secure, AI-driven data exchange platform that enables healthcare organizations to share real-world patient data. This platform enhances research and development, improves patient outcomes, and lowers costs by eliminating data silos and facilitating access to structured and unstructured data. With over 400 million patient records and a proven track record supported by top-tier investors, Lynx.MD is positioned as a leader in the healthcare data ecosystem, driving innovation and collaboration across the specialty medicine community.

Lynx.MD revolutionizes specialty medicine by providing a secure, AI-driven data exchange platform that enables healthcare organizations to share real-world patient data. This platform enhances research and development, improves patient outcomes, and lowers costs by eliminating data silos and facilitating access to structured and unstructured data. With over 400 million patient records and a proven track record supported by top-tier investors, Lynx.MD is positioned as a leader in the healthcare data ecosystem, driving innovation and collaboration across the specialty medicine community.
What they do: Secure, permissioned data platform for de-identified real-world clinical and operational data to support AI, research, and product development
Stage / funding: Multiple funding rounds; latest listed as a Seed round (Jan 2024); total funding reported ~$12M
Founded / HQ: Founded 2019; headquartered in Palo Alto, CA
Rebrand: Rebranded from Lynx.MD to Latica on December 30, 2024
Real-world clinical and operational healthcare data fragmentation that hampers AI development, clinical research, and product insights.
2019
Healthcare / Health data / MedTech
Most recent listed round on Jan 1, 2024 (Crunchbase entry)
“Backed by investors and corporate supporters including MizMaa Ventures, New Gate Capital, UpWest, Triventures, New York Life Ventures, iAngels, Amdocs, and Intel Ignite”